Chuck Grassley actually said...

Our investigation found that the PBM scheme encourages drug makers to spike the drug's list price in order to offer a greater rebate.

I hope this committee will have the same success voting this bill out.

I worked at the FTC, and I can tell you that with the Agency's overreach and activism, which will no doubt be difficult to sustain in court,...

Our bill has guardrails. It does not give FTC any new power or regulatory authority.